Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

October 16, 2020

Study Completion Date

October 16, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

TBPM-PI-HBr

TBPM-PI-HBr (3 x 200 mg tablets) once

Trial Locations (1)

Covance Clinical Research Unit, Inc., Madison